Rory J. McCrimmon

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

Shona Livingstone, Daniel L. Levin, Helen C. Looker et al. · JAMA · 2015 · 594 citations · Full text

Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening

Petros Perros, Rory J. McCrimmon, G. Shaw et al. · Diabetic Medicine · 1995 · 442 citations

Diabetes Management, Annual Screening, Thyroid Dysfunction +11

Synaptic Glutamate Release by Ventromedial Hypothalamic Neurons Is Part of the Neurocircuitry that Prevents Hypoglycemia

Qingchun Tong, Chianping Ye, Rory J. McCrimmon et al. · Cell Metabolism · 2007 · 404 citations · Full text

Synaptic Plasticity, Hypothalamus, Neurophysiology +15